TEL AVIV, Israel, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced…
Zürich (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse der UBS:
Die UBS-Analystin Ashwani Verma hat das Kursziel für die Aktie von TEVA Pharmaceutical Industries…
Teva Pharmaceutical Industries Ltd. (TEVA) ist ein Pharmaunternehmen mit Hauptsitz in Israel. Der Konzern ist vor allem als größter Generikahersteller…
Teva Pharmaceutical Industries (TEVA) saw its shares surge in the last session with trading volume being higher than average. The…
Kulmbach (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse vom Online-Anlegermagazin "Der Aktionär":
Michel Doepke von "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…
TEL AVIV, Israel, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Today, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)…
TEL AVIV, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today…
TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today…
TEVA earnings call for the period ending September 30, 2024.…
BRÜSSEL (dpa-AFX) - Weil der Arzneikonzern Teva aus Sicht der EU-Kommission seine marktbeherrschende Stellung missbraucht…
London (www.aktiencheck.de) - Rating-Update:
Die Analysten von Barclays bestätigen die Empfehlung für die Aktie von TEVA Pharmaceutical Industries Ltd. (ISIN: US8816242098,…
TEL AVIV, ISRAEL and MADRID, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals International GmbH, a subsidiary of…
TEL AVIV, Israel & PARSIPPANY, N.J., Sept. 21, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of…
TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 21, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of…
TEL AVIV, Israel, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today…
New York (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Jefferies & Co:
Jefferies & Co rät in einer aktuellen Aktienanalyse weiterhin zum Kauf…
Zürich (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von der UBS:
Die Analysten der UBS raten die Aktie von TEVA Pharmaceutical Industries Ltd. (ISIN:…
TEL AVIV, Israel, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today…
TEVA earnings call for the period ending June 30, 2024.…
The Global Consumer Health Market Size was Valued at USD 351.46 Billion in 2023 and the Worldwide Consumer Health Market…
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help…
New York (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Argus Research:
Jasper Hellweg, Analyst von Argus Research, stuft die ADR-Aktie von TEVA Pharmaceutical…
The Global Herpes Treatment Market Size was Valued at USD 1.23 Billion in 2023 and the Worldwide Herpes Treatment Market…
The Global Allergy Therapeutics Market Size was Valued at USD 23.1 Billion in 2023 and the Worldwide Allergy Therapeutics Market…
The Global Contraceptive Drugs Market Size was Valued at USD 18.53 Billion in 2023 and the Worldwide Contraceptive Drugs Market…
The Global Parkinsons Disease Treatment Market Size was Valued at USD 4.91 Billion in 2023 and the Worldwide Parkinsons Disease…
The Global Anal Fissure Treatment Market Size was Valued at USD 1161.3 Million in 2023 and the Worldwide Anal Fissure…
The Global Lenalidomide Drug Market Size was Valued at USD 12.34 Billion in 2023 and the Worldwide Lenalidomide Drug Market…
The Global Bipolar Disorder Market Size was Valued at USD 5.32 Billion in 2023, the Worldwide Bipolar Disorder Market Size…
The Global Prostate Health Market Size was Valued at USD 32.6 Billion in 2023 and the Worldwide Prostate Health Market…
London (www.aktiencheck.de) - Rating-Update:
Balaji Prasad, Analyst von Barclays, bestätigt die Empfehlung für die Aktie von TEVA Pharmaceutical Industries Ltd. (ISIN:…
Charlotte (www.aktiencheck.de) - Rating-Update:
BofA Securities stuft die Aktie von TEVA Pharmaceutical Industries Ltd. (ISIN: US8816242098, WKN: 883035, Ticker-Symbol: TEV, NYSE-Symbol:…
REYKJAVIK, Iceland and PARSIPPANY, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva…
REYKJAVIK, ICELAND & PARSIPPANY, NJ — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)…
Minneapolis (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Piper Sandler:
Piper Sandler erhöht in einer aktuellen Aktienanalyse das Kursziel für die Aktie von…
TEVA earnings call for the period ending March 31, 2024.…
REYKJAVIK, Iceland and PARSIPPANY, N.J., April 16, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a…
REYKJAVIK, ICELAND & PARSIPPANY, NJ — Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE…
The Global Pregabalin Market Size was Valued at USD 1.65 Billion in 2023 and the Worldwide Pregabalin Market Size is…
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
…
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 24, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a…
Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced…
For the first time since 2016, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) enlarged its workforce during 2023.…
More and more analysts are expressing confidence in the stock of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA).…
At the end of 2023, Israeli insurance and finance group The Phoenix Holdings’ stake in Teva was 5.4%.
Insurance…
Major antibiotics market players include F.Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd., Pfizer Inc., Abbott Laboratories, Merck…
TEVA earnings call for the period ending December 31, 2023.…
London (www.aktiencheck.de) - Rating-Update:
Balaji Prasad, Analyst von Barclays, bestätigt die Empfehlung für die Aktie von TEVA Pharmaceutical Industries Ltd. (ISIN:…
New York (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Jefferies & Co:
Glen Santangelo, Analyst von Jefferies & Co, stuft die ADR-Aktie von…